Open original FDA record ↗Recall record
- FDA identifier
- Z-0510-04
- Company in FDA record
- Abbott Laboratories HPD/ADD/GPRD
- FDA classification date
- Feb 4, 2004
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
The reagent package inserts for the products contain incorrect information in the Specific Performance Characteristics section. Accuracy by Correlation table
Source facts
- Action
- Field Correction recall by Important Product Information letter dated 12/5/03, sent via Federal Express Priority on the same date to all customers receiving the affected reagents. The accounts were informed of the incorrect values for the Specific Performance Characteristics listed in the package inserts of the reagent kits. The letters contained a table listing the incorrect values and the correct values for each of the products, and the users were instructed to replace their product inserts with the enclosed revised package inserts for all product specific reagent kits in their laboratory.
- Initiated
- 2003-12-05
- Root cause
- Other
- Terminated
- 2005-04-25
- Distribution
- Nationwide and internationally through Abbott subsidiaries in Mexico, Guatemala, Colombia, Chile, Argentina, Brazil, Puerto Rico, San Salvador, Canada, England, Japan, Singapore, Hong Kong, Taiwan, Thailand, Korea, Australia, New Zealand, Honduras, Costa Rica, Bahamas, Panama, Dominican Republic and China.
- Recall number
- Z-0510-04
- Recall status
- Terminated
- CDRH record ID
- 30828
- FDA classified
- 2004-02-04
- Recall event number
- 27971